Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$336M |
| 2 |
Truist Financial
TFC
|
+$144M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$103M |
| 4 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$91.6M |
| 5 |
Home Depot
HD
|
+$90.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$323M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$136M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$56.6M |
| 4 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$41.5M |
| 5 |
VSM
Versum Materials, Inc.
VSM
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.04% |
| 2 | Financials | 14.33% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 10.19% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Virgin Galactic
SPCE
$475M
| $3.74M | ﹤0.01% |
+16,200
| New | +$3.16M |
|
2177
Krystal Biotech
KRYS
$9.72B
| $3.73M | ﹤0.01% |
67,364
+1,336
| +2% | +$65.5K |
|
2178
TechTarget
TTGT
$277M
| $3.73M | ﹤0.01% |
142,705
+3,999
| +3% | +$101K |
|
2179
Talos Energy
TALO
$2.58B
| $3.72M | ﹤0.01% |
123,293
+2,614
| +2% | +$61K |
|
|
YMAB
2180
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.7M | ﹤0.01% |
118,528
+31,374
| +36% | +$928K |
|
2181
CEVA Inc
CEVA
$855M
| $3.69M | ﹤0.01% |
136,782
+2,384
| +2% | +$65.1K |
|
|
FFIC
2182
DELISTED
Flushing Financial
FFIC
| $3.69M | ﹤0.01% |
170,587
+3,124
| +2% | +$66.5K |
|
2183
Mercantile Bank Corp
MBWM
$1.06B
| $3.66M | ﹤0.01% |
100,396
+2,059
| +2% | +$72.4K |
|
2184
LeMaitre Vascular
LMAT
$1.87B
| $3.66M | ﹤0.01% |
101,715
+2,963
| +3% | +$102K |
|
2185
NIO
NIO
$11.3B
| $3.64M | ﹤0.01% |
905,582
+704,684
| +351% | +$1.42M |
|
2186
Northern Oil and Gas
NOG
$2.61B
| $3.63M | ﹤0.01% |
155,323
+6,276
| +4% | +$124K |
|
2187
Cerus
CERS
$572M
| $3.63M | ﹤0.01% |
859,531
+21,787
| +3% | +$93.9K |
|
|
NVO
2188
Novo Nordisk
NVO
$205B
| $3.63M | ﹤0.01% |
125,286
-134,690
| -52% | -$3.73M |
|
|
AHT
2189
Ashford Hospitality Trust
AHT
$20.2M
| $3.62M | ﹤0.01% |
1,297
+50
| +4% | +$140K |
|
2190
Opko Health
OPK
$1.04B
| $3.62M | ﹤0.01% |
2,462,420
+25,271
| +1% | +$42.3K |
|
2191
Dime Commercial Bancshares
DCOM
$1.82B
| $3.62M | ﹤0.01% |
107,852
+2,241
| +2% | +$72K |
|
2192
AngioDynamics
ANGO
$647M
| $3.62M | ﹤0.01% |
225,826
+4,294
| +2% | +$65.6K |
|
|
RUTH
2193
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $3.62M | ﹤0.01% |
166,122
-470
| -0.3% | -$10.3K |
|
2194
Intellia Therapeutics
NTLA
$1.66B
| $3.58M | ﹤0.01% |
244,195
+5,695
| +2% | +$79.2K |
|
2195
Monarch Casino & Resort
MCRI
$2.2B
| $3.58M | ﹤0.01% |
73,723
+1,556
| +2% | +$69.2K |
|
2196
Beyond Meat
BYND
$210M
| $3.58M | ﹤0.01% |
47,339
+3,557
| +8% | +$330K |
|
|
LGF.A
2197
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $3.58M | ﹤0.01% |
335,384
+29,227
| +10% | +$269K |
|
|
QADA
2198
DELISTED
QAD Inc.
QADA
| $3.57M | ﹤0.01% |
70,143
+2,981
| +4% | +$143K |
|
|
JOYY
2199
JOYY Inc
JOYY
$3.64B
| $3.57M | ﹤0.01% |
67,560
+1,571
| +2% | +$92.5K |
|
2200
Liberty Energy
LBRT
$3.45B
| $3.56M | ﹤0.01% |
320,479
+8,730
| +3% | +$82.8K |
|
Similar funds
Charles Schwab's Q4 2019 Portfolio in Review
As of Q4 2019, Charles Schwab held 3,227 positions worth $186B, up 9.8% from $169B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 3%. Charles Schwab opened 50 new positions and exited 48, leaving the 3,227-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2019 buy was Apollo Global Management: 821,197 shares worth $39.2M.
- Charles Schwab added most to Bristol-Myers Squibb in Q4 2019, an estimated $336M increase.
- Charles Schwab's biggest Q4 2019 reduction was Bank of America, cutting an estimated $34M.
- Charles Schwab fully exited Celgene Corp in Q4 2019, selling an estimated $323M.
- Charles Schwab's ten largest holdings make up 16% of its $186B portfolio in Q4 2019.
- Charles Schwab opened 50 new positions and closed 48 in Q4 2019.
- Charles Schwab's portfolio value rose 9.8% quarter-over-quarter to $186B.
Based on Charles Schwab's 13F filing for Q4 2019, filed 7 Feb 2020.